Michael Glaubitz

682 total citations
17 papers, 502 citations indexed

About

Michael Glaubitz is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Michael Glaubitz has authored 17 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Michael Glaubitz's work include Cervical Cancer and HPV Research (4 papers), Cutaneous Melanoma Detection and Management (3 papers) and Reproductive tract infections research (2 papers). Michael Glaubitz is often cited by papers focused on Cervical Cancer and HPV Research (4 papers), Cutaneous Melanoma Detection and Management (3 papers) and Reproductive tract infections research (2 papers). Michael Glaubitz collaborates with scholars based in Germany, United States and Slovakia. Michael Glaubitz's co-authors include H. Kühnle, Heinrich G. Köchel, Ulrike Bode, S Niesert, Karl Ulrich Petry, I. Schedel, E. Kupsch, Mihaela Delcea, Nikolay Medvedev and Christiane A. Helm and has published in prestigious journals such as Circulation, Cancer and International Journal of Cancer.

In The Last Decade

Michael Glaubitz

17 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Glaubitz Germany 9 244 149 123 93 52 17 502
Carlos Medina United States 17 88 0.4× 79 0.5× 185 1.5× 84 0.9× 105 2.0× 27 665
P H Maddox United Kingdom 7 190 0.8× 78 0.5× 84 0.7× 84 0.9× 119 2.3× 8 490
B.S. Sylla France 12 237 1.0× 133 0.9× 138 1.1× 75 0.8× 160 3.1× 20 580
Huub J J M Rennen Netherlands 15 138 0.6× 80 0.5× 369 3.0× 72 0.8× 75 1.4× 24 680
Jean‐Luc Perrot France 12 114 0.5× 163 1.1× 58 0.5× 68 0.7× 52 1.0× 36 560
Raymond C. Yu United Kingdom 14 242 1.0× 149 1.0× 233 1.9× 213 2.3× 75 1.4× 36 901
Agnieszka Żebrowska Poland 13 33 0.1× 30 0.2× 39 0.3× 76 0.8× 93 1.8× 79 566
James Waldman United States 9 489 2.0× 109 0.7× 73 0.6× 294 3.2× 64 1.2× 10 716
Sean Burke United States 12 108 0.4× 42 0.3× 63 0.5× 64 0.7× 151 2.9× 15 626
Sun D China 13 86 0.4× 100 0.7× 86 0.7× 40 0.4× 392 7.5× 56 705

Countries citing papers authored by Michael Glaubitz

Since Specialization
Citations

This map shows the geographic impact of Michael Glaubitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Glaubitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Glaubitz more than expected).

Fields of papers citing papers by Michael Glaubitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Glaubitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Glaubitz. The network helps show where Michael Glaubitz may publish in the future.

Co-authorship network of co-authors of Michael Glaubitz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Glaubitz. A scholar is included among the top collaborators of Michael Glaubitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Glaubitz. Michael Glaubitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Strohbach, Anne, Michael Glaubitz, Raghavendra Palankar, et al.. (2018). The apelin receptor influences biomechanical and morphological properties of endothelial cells. Journal of Cellular Physiology. 233(8). 6250–6261. 19 indexed citations
2.
Palankar, Raghavendra, Michael Glaubitz, Ulrike Martens, et al.. (2016). Stem Cell Mechanobiology: 3D Micropillars Guide the Mechanobiology of Human Induced Pluripotent Stem Cell‐Derived Cardiomyocytes (Adv. Healthcare Mater. 3/2016). Advanced Healthcare Materials. 5(3). 334–334. 1 indexed citations
3.
Glaubitz, Michael, Stefan Groß, Raghavendra Palankar, et al.. (2015). Human neutrophil antigen‐3a antibodies induce neutrophil stiffening and conformational activation of CD11b without shedding of L‐selectin. Transfusion. 55(12). 2939–2948. 4 indexed citations
4.
Palankar, Raghavendra, Michael Glaubitz, Ulrike Martens, et al.. (2015). 3D Micropillars Guide the Mechanobiology of Human Induced Pluripotent Stem Cell‐Derived Cardiomyocytes. Advanced Healthcare Materials. 5(3). 335–341. 14 indexed citations
5.
Glaubitz, Michael, Nikolay Medvedev, Daniel Pussak, et al.. (2014). A novel contact model for AFM indentation experiments on soft spherical cell-like particles. Soft Matter. 10(35). 6732–6732. 69 indexed citations
6.
Glaubitz, Michael, Stephan Block, Klaus Empen, et al.. (2014). Stiffness of Left Ventricular Cardiac Fibroblasts Is Associated With Ventricular Dilation in Patients With Recent-Onset Nonischemic and Nonvalvular Cardiomyopathy. Circulation Journal. 78(7). 1693–1700. 10 indexed citations
7.
Glaubitz, Michael, et al.. (1997). Phase I study of weekly docetaxel (Taxotere®) in heavily pretreated breast cancer patients. European Journal of Cancer. 33. S158–S158. 28 indexed citations
8.
Böhmer, Gerd, et al.. (1996). Die HPV-DNA-Hybridisierung ermöglicht eine Differenzierung zervikaler Läsionen bei PAP III Zytobefunden. Geburtshilfe und Frauenheilkunde. 56(10). 509–512. 1 indexed citations
9.
Glaubitz, Michael, et al.. (1996). Die elektrochirurgische Schlingenexzision der Transformationszone (LEEP) zur Behandlung zervikaler Neoplasien. Geburtshilfe und Frauenheilkunde. 56(10). 513–516. 3 indexed citations
10.
Jackisch, Christian, M Hundeiker, Achim Heinecke, et al.. (1996). Malignant melanoma of the vulva: Report of 89 patients. Cancer. 78(11). 2353–2358. 53 indexed citations
11.
Petry, Karl Ulrich, Heinrich G. Köchel, Ulrike Bode, et al.. (1996). Human Papillomavirus Is Associated with the Frequent Detection of Warty and Basaloid High-Grade Neoplasia of the Vulva and Cervical Neoplasia among Immunocompromised Women. Gynecologic Oncology. 60(1). 30–34. 46 indexed citations
12.
Bois, Andreas du, et al.. (1995). Pattern of carboplatin-induced emesis. Anti-Cancer Drugs. 6(5). 645–651. 8 indexed citations
13.
Petry, Karl Ulrich, Ulrike Bode, Heinrich G. Köchel, et al.. (1994). Cellular immunodeficiency enhances the progression of human papillomavirus‐associated cervical lesions. International Journal of Cancer. 57(6). 836–840. 197 indexed citations
14.
Glaubitz, Michael, et al.. (1994). Primary squamous cell carcinoma of the endometrium. Case report and review of the literature.. PubMed. 15(1). 37–42. 5 indexed citations
15.
Glaubitz, Michael, et al.. (1992). Uterine Metastasen maligner Melanome. Geburtshilfe und Frauenheilkunde. 52(2). 92–95. 6 indexed citations
16.
Glaubitz, Michael, et al.. (1992). [Malignant melanoma in gynecology].. PubMed. 114(2). 59–67. 1 indexed citations
17.
Figulla, Hans R, F. Vetterlein, Michael Glaubitz, & H Kreuzer. (1987). Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster.. Circulation. 76(1). 208–216. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026